Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 2.2% | n/a |
ROCE | 2.8% |
Latest | F'cast | |
---|---|---|
P/E | 35.2 | n/a |
PEG | n/a | n/a |
Pr/Revenue | 4.4 | n/a |
Pr/Book | 5.0 |
Latest | F'cast | |
---|---|---|
Revenue | 96.5% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 204.89 | (141.10) | (16.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 227.98 | (189.73) | (18.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 356.13 | (215.74) | (0.25)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 426.41 | (410.42) | (43.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 838.00 | 58.31 | 12.00¢ | 29.5 | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Result of AGM | 10-May-2024 | 13:00 | RNS |
Directorate Change | 08-May-2024 | 09:30 | RNS |
Positive CHMP Opinion for Fruquintinib | 26-Apr-2024 | 13:30 | RNS |
Chinese medicine firm employs Cambridge Universi... | 23-Dec-2009 | Guardian |
Joint venture offers food for growth | 09-Oct-2009 | The Scotsman |
Chi-Med unveils maiden profit | 31-Jul-2009 | The Scotsman |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
20-Apr-24 | Transfer From | Graeme Allan Jack | 0.000p | 11,985 | £0.00 |
20-Apr-24 | Transfer From | Paul Rutherford Carter | 0.000p | 10,190 | £0.00 |
20-Apr-24 | Transfer From | Dan Eldar | 0.000p | 11,985 | £0.00 |
Currency | UK Pounds |
Share Price | 348.00p |
Change Today | 10.00p |
% Change | 2.96 % |
52 Week High | 353.00 |
52 Week Low | 173.60 |
Volume | 137,949 |
Shares Issued | 871.26m |
Market Cap | £3,031.97m |
RiskGrade | 226 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
13:16 | 1,754 @ 348.00p |
13:16 | 1,128 @ 348.00p |
12:52 | 2,632 @ 348.00p |
12:51 | 24 @ 349.00p |
12:51 | 31 @ 349.00p |
You are here: research